Companies/US/CSTL

CASTLE BIOSCIENCES, INC.

Income flow

Annual
CSTL 10-K Income StatementPeriod 2025-12-31Source 10-K
Dermatologic$216MNon Dermatologic$128MRevenue$344M+4% Y/YGross profit$273MCost of revenue$71M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$344M
  • Dermatologic$216M62.9%
  • Non Dermatologic$128M37.1%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).30.5MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).27.2M